By Jon Armstrong Posted March 7, 2016 InShared ncRNA Transcripts2016-03-072016-03-07https://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.pngCofactor Genomicshttps://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.png200px200px Recent PostsCofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy TestCofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer PatientsCofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to ImmunotherapyPrecision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics’ Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals